CSL PHARMA-ADVICE ApS: Financial statements 2017
CVR: 36501693
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
CSL PHARMA-ADVICE ApS (CVR 36501693) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 404,000 and a net result of DKK 261,918 compared with DKK 145,190 the year before. That is an increase of 62.2% compared with the year before. The profit margin was 64.8%. Equity in the 2017 report amounted to DKK 571,276. The solvency ratio was 81.5%.
- Revenue
- DKK 404,000
- Gross Profit
- DKK 337,231
- Profit/Loss
- DKK 261,918
- Equity
- DKK 571,276
- Total Assets
- DKK 701,004
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 404 t. | 337 t. | 262 t. | 571 t. | - |
| 2016 | 249 t. | 189 t. | 145 t. | 309 t. | - |
| 2015 | 155 t. | 151 t. | 114 t. | 164 t. | - |
Official annual report
Keep an eye on CSL PHARMA-ADVICE ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
CSL PHARMA-ADVICE ApS has published its annual report for 2016. Revenue came to DKK 248,999, and the net result was DKK 145,190.
About CSL PHARMA-ADVICE ApS
CSL PHARMA-ADVICE ApS was a Danish company of the type Anpartsselskab based in Lejre, founded in 2015. The company has been dissolved on 4 January 2024. The company was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse. In 2022, the company reported a gross profit of DKK 30,604 and a net result of DKK 32,496 compared with DKK -44,528 the year before. Equity in the 2022 report amounted to DKK 133,890.